Stock DGX QUEST DIAGNOSTICS INCORPORATED
Add to a list
To use this feature you must be a member
Log inSign up

Highlights Quest Diagnostics Incorporated

Equities

DGX

US74834L1008

Market Closed - Nyse
Other stock markets
 01:00:02 2024-07-03 pm EDT 		5-day change 1st Jan Change
140.9 USD +3.12% Intraday chart for Quest Diagnostics Incorporated +2.59% +2.19%
12:05pm Baird Adjusts Price Target on Quest Diagnostics to $153 From $145, Maintains Neutral Rating MT
11:46am ANALYST RECOMMENDATIONS : Tesla, Constellations Brands, Old Dominion, Stellantis, Lloyds... Our Logo

Highlights

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
Quest Diagnostics to Buy LifeLabs From OMERS
MT
Quest Diagnostics to Buy LifeLabs From OMERS
MT
Quest Diagnostics expands into Canada with nearly $1 bln LifeLabs deal
RE
Quest Diagnostics to acquire LifeLabs for $985 million
RE
Quest Diagnostics to Acquire Lab Assets From Allina Health
MT
Quest Diagnostics Incorporated agreed to acquire Select Laboratory Assets of Allina Health from Allina Health System, Inc.
CI
Quest Diagnostics Incorporated entered definitive agreement to acquire Select laboratory assets of Allina Health System, Inc.
CI
Quest Diagnostics Completes Acquisition of PathAI Diagnostics From PathAI
MT
Quest Diagnostics Completes Acquisition of PathAI Diagnostics From PathAI
MT
Quest Diagnostics Incorporated completed the acquisition of Select assets of PathAI Diagnostics.
CI
Quest Diagnostics Keeps Quarterly Cash Dividend at $0.75 a Share, Payable on July 22 to Shareholders of Record on July 8
MT
Quest Diagnostics Incorporated Declares Quarterly Cash Dividend, Payable on July 22, 2024
CI
Ontario Municipal Employees Retirement System Reportedly in Advanced Talks to Sell LifeLabs Medical Laboratory Services to Quest Diagnostics
CI
Quest Diagnostics to Acquire PathAI Diagnostics Assets in Collaboration Deal
MT
Quest Diagnostics Forms Licensing Agreements with PathAI
CI
Quest Diagnostics Incorporated agreed to acquire Select assets of PathAI Diagnostics.
CI
US FDA publishes final rule for laboratory developed tests
RE
Labcorp beats quarterly estimates on strong testing demand
RE
Tranche Update on Quest Diagnostics Incorporated's Equity Buyback Plan announced on October 20, 2010.
CI
Quest Diagnostics Posts Flat Q1 Adjusted Earnings, Revenue Rises; 2024 Earnings, Revenue Guidance Raised
MT
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. DGX Stock
  4. News Quest Diagnostics Incorporated
  5. Highlights